Sunday, 2 November 2014

The New DSM 5 and the controversy

http://www.nhs.uk/news/2013/08august/pages/controversy-mental-health-diagnosis-and-treatment-dsm5.aspx

2 comments:

  1. It's a little obvious that the pharmaceutical industry holds too much sway regarding treatment of mental health conditions. Pharmalogical solutions should not be favoured over therapeutic solutions in such a biased way..too much emphasis on nature, not enough on nurture..;)

    ReplyDelete
    Replies
    1. This is so true they are going to have an invested interest in biological treatments. Money has to be made so it suits those that profit to treat mental illness in a biological way.....

      Delete